Vol 43, No 2 (2012)
Review
Published online: 2012-09-01

open access

Page views 200
Article views/downloads 2013
Get Citation

Connect on Social Media

Connect on Social Media

The role of receptor programmed death-1 and its ligands in immune system and tumors

Maciej Grzywnowicz1, Krzysztof Giannopoulos
DOI: 10.1016/S0001-5814(12)32008-2
Acta Haematol Pol 2012;43(2):132-145.

Abstract

programmed death-1 (pD-1) molecule is an immunoreceptor, which is inducibly expressed on both T and B lymphocytes. pD-1 is a negative regulator of the immune response. Through interactions with its ligands: pD-L1 and pD-L2, being expressed on wide range of tissue, pD-1 is responsible for maintenance of peripheral tolerance by restricting activation, proliferation and effector functions of T lymphocytes. Aberrations of the pD-1/pD-L pathway lead to autoimmune disorders and are observed on exhausted lymphocytes during chronic infections. Expression of pD-1 and its ligands is described in many tumor entities, where it modulates tumor microenviroment and might be a potential escape mechanism from immunosurveillance. There are growing evidences for potential therapeutical applications of the pD-1/pD-L pathway, including heamatological malignances.

Article available in PDF format

View PDF (Polish) Download PDF file